Toho Holdings Co., Ltd. Provides Earnings Guidance for the Six Months Ending September 2022 and for Year Ending March 31, 2023
May 13, 2022 at 12:00 am EDT
Share
Toho Holdings Co., Ltd. provided earnings guidance for the six months ending September 2022 and for year ending March 31, 2023. For the six months, the company expects net sales of JPY 630,000 million, Operating profit of JPY 5,700 million, Profit attributable to owners of parent of JPY 5,600 million and basic earnings per share of JPY 79.39.
For the year, the company expects net sales of JPY 1,269,000 million, Operating profit of JPY 12,300 million, Profit attributable to owners of parent of JPY 11,300 million and basic earnings per share of JPY 160.19.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
TOHO HOLDINGS CO., LTD. 
